- Home
- ACHR vs CRL Comparison
ACHR vs CRL Comparison
Compare ACHR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHR
- CRL
- Stock Information
- Founded
- ACHR 2018
- CRL 1947
- Country
- ACHR United States
- CRL United States
- Employees
- ACHR N/A
- CRL N/A
- Industry
- ACHR Aerospace
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ACHR Industrials
- CRL Health Care
- Exchange
- ACHR Nasdaq
- CRL Nasdaq
- Market Cap
- ACHR 6.4B
- CRL 7.1B
- IPO Year
- ACHR N/A
- CRL 2000
- Fundamental
- Price
- ACHR $10.61
- CRL $159.42
- Analyst Decision
- ACHR Strong Buy
- CRL Buy
- Analyst Count
- ACHR 8
- CRL 14
- Target Price
- ACHR $13.13
- CRL $184.85
- AVG Volume (30 Days)
- ACHR 42.7M
- CRL 831.6K
- Earning Date
- ACHR 08-07-2025
- CRL 08-06-2025
- Dividend Yield
- ACHR N/A
- CRL N/A
- EPS Growth
- ACHR N/A
- CRL N/A
- EPS
- ACHR N/A
- CRL N/A
- Revenue
- ACHR N/A
- CRL $4,022,597,000.00
- Revenue This Year
- ACHR N/A
- CRL N/A
- Revenue Next Year
- ACHR N/A
- CRL $2.49
- P/E Ratio
- ACHR N/A
- CRL N/A
- Revenue Growth
- ACHR N/A
- CRL N/A
- 52 Week Low
- ACHR $2.82
- CRL $91.86
- 52 Week High
- ACHR $13.92
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- ACHR 53.08
- CRL 62.71
- Support Level
- ACHR $9.76
- CRL $152.73
- Resistance Level
- ACHR $11.06
- CRL $168.12
- Average True Range (ATR)
- ACHR 0.58
- CRL 5.21
- MACD
- ACHR 0.02
- CRL 0.49
- Stochastic Oscillator
- ACHR 63.81
- CRL 63.37
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.